Literature DB >> 16437534

Psychological therapies for people with borderline personality disorder.

C A Binks1, M Fenton, L McCarthy, T Lee, C E Adams, C Duggan.   

Abstract

BACKGROUND: Borderline personality disorder (BPD) is a relatively common personality disorder with a major impact on health services as those affected often present in crisis, often self-harming.
OBJECTIVES: To evaluate the effects of psychological interventions for people with borderline personality disorder. SEARCH STRATEGY: We conducted a systematic search of 26 specialist and general bibliographic databases (December 2002) and searched relevant reference lists for further trials. SELECTION CRITERIA: All relevant clinical randomised controlled trials involving psychological treatments for people with BPD. The definition of psychological treatments included behavioural, cognitive-behavioural, psychodynamic and psychoanalytic. DATA COLLECTION AND ANALYSIS: We independently selected, quality assessed and data extracted studies. For binary outcomes we calculated a standard estimation of the risk ratio (RR), its 95% confidence interval (CI), and where possible the number need to help/harm (NNT/H). For continuous outcomes, endpoint data were preferred to change data. Non-skewed data from valid scales were summated using a weighted mean difference (WMD). MAIN
RESULTS: We identified seven studies involving 262 people, and five separate comparisons. Comparing dialectical behaviour therapy (DBT) with treatment as usual studies found no difference for the outcome of still meeting SCID-II criteria for the diagnosis of BPD by six months (n=28, 1 RCT, RR 0.69 CI 0.35 to 1.38) or admission to hospital in previous three months (n=28, 1 RCT, RR 0.77 CI 0.28 to 2.14). Self harm or parasuicide may decrease at 6 to 12 months (n=63, 1 RCT, RR 0.81 CI 0.66 to 0.98, NNT 12 CI 7 to 108). One study detected statistical difference in favour of people receiving DBT compared with those allocated to treatment as usual for average scores of suicidal ideation at 6 months (n=20, MD -15.30 CI -25.46 to -5.14). There was no difference for the outcome of leaving the study early (n=155, 3 RCTs, RR 0.74 CI 0.52 to 1.04). For the outcome of interviewer-assessed alcohol free days, skewed data are reported and tend to favour DBT. When a substance abuse focused DBT was compared with comprehensive validation therapy plus 12-step substance misuse programme no clear differences were found for service outcomes (n=23, 1 RCT, RR imprisoned 1.09 CI 0.64 to 1.87) or leaving the study early (n=23, 1 RCT, RR 7.58 CI 0.44 to 132.08). When dialectical behaviour therapy-oriented treatment is compared with client centred therapy no differences were found for service outcomes (n=24, 1 RCT, RR admitted 0.33 CI 0.08 to 1.33). However, fewer people in the DBT group displayed indicators of parasuicidal behaviour (n=24, RR 0.13 CI 0.02 to 0.85, NNT 2 CI 2 to 11). There were no differences for outcomes of anxiety and depression (n=24, 1 RCT, RR anxiety BAI >/=10 0.60 CI 0.32 to 1.12; RR depression HDRS >/=10 0.43 CI 0.14 to 1.28) but people who received DBT had less general psychiatric severity than those in the control (MD BPRS at 6 months -7.41 CI -13.72 to -1.10). Finally this one relevant study reports skewed data for suicidal ideation with considerably lower scores for people allocated to DBT. When psychoanalytically oriented partial hospitalization was compared with general psychiatric care the former tended to come off best. People who received treatment in a psychoanalytic orientated day hospital were less likely to be admitted into inpatient care when measured at different time points (e.g. n=44, RR admitted to inpatient 24 hour care >18 to 24 months 0.05 CI 0.00 to 0.77, NNT 3 CI 3 to 10) Fewer people in psychoanalytically oriented partial hospitalization needed day hospital intervention in the 18 months after discharge (n=44, 1 RCT, RR 0.04 CI 0.00 to 0.59, NNT 2 CI 2 to 8). More people in the control group took psychotropic medication by the 30 to 36 month follow-up, than those receiving psychoanalytic treatment (n=44, 1 RCT, RR 0.44 CI 0.25 to 0.80, NNT 3 CI 2 to 7). Anxiety and depression scores were generally lower in the psychoanalytically oriented partial hospitalization group (n=44, 1 RCT, RR >/=14 on BDI 0.52 CI 0.34 to 0.80, NNT 3 CI 3 to 6), as are global severity scores. People receiving psychoanalytic care in a day hospital had better social improvement in social adjustment using the SAS-SR at 6 to 12 months compared with people in general psychiatric care (MD -0.70 CI -1.08 to -0.32). Rates of attrition were the same (n=44, 1 RCT, RR leaving the study early 1.00 CI 0.23 to 4.42). AUTHORS'
CONCLUSIONS: This review suggests that some of the problems frequently encountered by people with borderline personality disorder may be amenable to talking/behavioural treatments but all therapies remain experimental and the studies are too few and small to inspire full confidence in their results. These findings require replication in larger 'real-world' studies.

Entities:  

Mesh:

Year:  2006        PMID: 16437534     DOI: 10.1002/14651858.CD005652

Source DB:  PubMed          Journal:  Cochrane Database Syst Rev        ISSN: 1361-6137


  36 in total

Review 1.  Effectiveness of different psychotherapy approaches in the treatment of borderline personality disorder.

Authors:  Joel Paris
Journal:  Curr Psychiatry Rep       Date:  2010-02       Impact factor: 5.285

2.  Accurately diagnosing and treating borderline personality disorder: a psychotherapeutic case.

Authors:  Ashley B Johnson; Julie P Gentile; Terry L Correll
Journal:  Psychiatry (Edgmont)       Date:  2010-04

3.  Scales to climb borderline personalities: when science goes nowhere.

Authors:  L Moja; G Virgili; A Liberati; G F Gensini; R Gusinu; A A Conti
Journal:  Intern Emerg Med       Date:  2007-12       Impact factor: 3.397

Review 4.  [Evidence-based psychotherapy: addiction and personality disorders as comorbidities].

Authors:  T Kienast; E Roediger; M Kensche; J Foerster; I Daig; A Heinz
Journal:  Nervenarzt       Date:  2009-09       Impact factor: 1.214

Review 5.  A Focused Systematic Review of Pharmacological Treatment for Borderline Personality Disorder.

Authors:  Ella Hancock-Johnson; Chris Griffiths; Marco Picchioni
Journal:  CNS Drugs       Date:  2017-05       Impact factor: 5.749

Review 6.  Management of borderline personality disorder.

Authors:  Robert S Biskin; Joel Paris
Journal:  CMAJ       Date:  2012-10-01       Impact factor: 8.262

Review 7.  The association of bipolar spectrum disorders and borderline personality disorder.

Authors:  Diomidis Antoniadis; Maria Samakouri; Miltos Livaditis
Journal:  Psychiatr Q       Date:  2012-12

8.  Higher executive control and visual memory performance predict treatment completion in borderline personality disorder.

Authors:  Eric A Fertuck; John Keilp; Inkyung Song; Melissa C Morris; Scott T Wilson; Beth S Brodsky; Barbara Stanley
Journal:  Psychother Psychosom       Date:  2011-11-22       Impact factor: 17.659

9.  Qualitative Analysis of Resources and Barriers Related to Treatment of Borderline Personality Disorder in the United States.

Authors:  Matthew C Lohman; Karen L Whiteman; Frank E Yeomans; Sheila A Cherico; Winifred R Christ
Journal:  Psychiatr Serv       Date:  2016-10-03       Impact factor: 3.084

10.  The Efficacy of Cognitive Behavioral Therapy: A Review of Meta-analyses.

Authors:  Stefan G Hofmann; Anu Asnaani; Imke J J Vonk; Alice T Sawyer; Angela Fang
Journal:  Cognit Ther Res       Date:  2012-07-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.